Thomas Edward Hamilton

Thomas Edward Hamilton serves as director at Larimar Therapeutics, Inc. (LRMR). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

4 trades

$2.50M

Total Sells

1 trades

$734.4K

Net Position

Net Buyer

$1.76M

Companies Traded

2

LRMR, NLY

Active Period

May 2021 – Mar 2026

5 total trades

Most Recent

Buy LRMR

Mar 2, 2026 · $500.0K

Thomas Edward Hamilton's Insider Trading at Larimar Therapeutics, Inc. (LRMR)

Buys

4 · $2.50M

Sells

0 · $0.00

Total Shares Bought

531,378

Total Shares Sold

0

LRMR Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Mar 2, 2026	Buy	100,000	$5.00	$500.0K	664,798
May 31, 2024	Buy	57,208	$8.74	$500.0K	564,798
Sep 20, 2022	Buy	317,460	$3.15	$1000.0K	507,590
Jul 2, 2021	Buy	56,710	$8.75	$496.2K	190,130

Thomas Edward Hamilton's Insider Trading at Annaly Capital Management, Inc. (NLY)

Buys

0 · $0.00

Sells

1 · $734.4K

Total Shares Bought

0

Total Shares Sold

80,000

NLY Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
May 4, 2021	Sell	80,000	$9.18	$734.4K	0

Related Insiders

James E Flynn

director, 10 percent owner, other: * Director by Deputization

LRMRBuy · Mar 2, 2026

SHERMAN JEFFREY W

director

LRMRBuy · Mar 2, 2026

THOMAS FRANK E

director

LRMRBuy · Mar 2, 2026

Steven Francis Campbell

President and COO

NLYSell · Feb 27, 2026

Serena Wolfe

Chief Financial Officer

NLYSell · Feb 1, 2026

David L Finkelstein

CEO and Co-CIO

NLYSell · Feb 1, 2026

Anthony C Green

Chief Corporate Officer, CLO

NLYSell · Nov 3, 2025

Explore More Insider Trading Data

LRMR Insider Trading Activity

View all insider trades at Larimar Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity